全球智慧型胰岛素笔市场规模、份额、趋势和成长分析报告（2026-2034年）

预计到 2034 年，智慧胰岛素笔市场规模将达到 25.237 亿美元，高于 2025 年的 9.3306 亿美元，预计从 2026 年到 2034 年的复合年增长率将达到 11.69%。

随着数位医疗技术革新糖尿病管理方式，全球智慧胰岛素笔市场正快速成长。智慧胰岛素笔是一种先进的设备，可帮助患者註射胰岛素，同时追踪剂量、注射时间和使用模式。这些设备通常与行动应用程式配合使用，使用户和医疗专业人员能够更有效地监测胰岛素的输注。全球糖尿病盛行率的不断上升，显着推动了对这些创新设备的需求。

市场成长的驱动因素包括对改善糖尿病管理的需求日益增长以及患者对胰岛素治疗的依从性提高。智慧胰岛素笔提供剂量提醒、自动追踪和与医疗专业人员共用数据等功能。这些功能有助于患者更好地控制血糖值，并降低剂量错误的风险。

智慧胰岛素笔市场预计将受益于数位医疗技术的持续进步。与持续血糖监测系统和行动医疗平台的整合，可提供更全面的糖尿病管理解决方案。新兴市场健康意识的提高和糖尿病护理服务覆盖范围的扩大，将进一步推动智慧胰岛素笔的普及。随着数位医疗解决方案的不断发展，智慧胰岛素笔仍将是糖尿病治疗的重要工具。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球智慧胰岛素笔市场：连结性

• 市场分析、洞察与预测
• Bluetooth
• 近距离场通讯（NFC）

第五章：全球智慧胰岛素笔市场：依适应症划分

• 市场分析、洞察与预测
• 1型糖尿病
• 2型糖尿病

第六章：全球智慧胰岛素笔市场：依通路划分

• 市场分析、洞察与预测
• 医院药房
• 实体店和网路药局

第七章 全球智慧胰岛素笔市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Novo Nordisk A/S
  • Medtronic
  • Ypsomed AG
  • Emperra GmbH
  • Pendiq
  • Jiangsu Deflu Medical Device Co
  • Cambridge Consultants Ltd
  • Diabnext

The Smart Insulin Pens Market size is expected to reach USD 2523.70 Million in 2034 from USD 933.06 Million (2025) growing at a CAGR of 11.69% during 2026-2034.

The global smart insulin pens market has grown rapidly as digital health technologies transform diabetes management. Smart insulin pens are advanced devices that help patients administer insulin while tracking dosage, timing, and usage patterns. These devices often connect to mobile applications, allowing users and healthcare providers to monitor insulin administration more effectively. The increasing global prevalence of diabetes has significantly contributed to the demand for these innovative devices.

Several factors are driving market growth, including the rising need for improved diabetes management and patient adherence to insulin therapy. Smart insulin pens offer features such as dose reminders, automatic tracking, and data sharing with healthcare professionals. These capabilities help patients maintain better control over blood glucose levels and reduce the risk of dosing errors.

Looking forward, the smart insulin pens market is expected to benefit from continued advancements in digital healthcare technologies. Integration with continuous glucose monitoring systems and mobile health platforms may provide more comprehensive diabetes management solutions. Increasing healthcare awareness and expanding access to diabetes care in emerging markets will likely drive further adoption. As digital health solutions continue to evolve, smart insulin pens will remain an important tool in diabetes treatment.

MARKET SEGMENTATION

By Connectivity

• Bluetooth
• Near Field Communication (NFC)

By Indication

• Type 1 Diabetes
• Type 2 Diabetes

By Distribution Channel

• Hospital Pharmacies
• Retail & Online Pharmacies

COMPANIES PROFILED

• Novo Nordisk AS, Medtronic, Ypsomed AG, Emperra GmbH, Pendiq, Jiangsu Deflu Medical Device Co, Cambridge Consultants Ltd, Diabnext
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SMART INSULIN PENS MARKET: BY CONNECTIVITY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Connectivity
• 4.2. Bluetooth Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Near Field Communication (NFC) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SMART INSULIN PENS MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Type 1 Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Type 2 Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SMART INSULIN PENS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail & Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SMART INSULIN PENS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Connectivity
  • 7.2.2 By Indication
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Connectivity
  • 7.3.2 By Indication
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Connectivity
  • 7.4.2 By Indication
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Connectivity
  • 7.5.2 By Indication
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Connectivity
  • 7.6.2 By Indication
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SMART INSULIN PENS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Novo Nordisk A/S
  • 9.2.2 Medtronic
  • 9.2.3 Ypsomed AG
  • 9.2.4 Emperra GmbH
  • 9.2.5 Pendiq
  • 9.2.6 Jiangsu Deflu Medical Device Co
  • 9.2.7 Cambridge Consultants Ltd
  • 9.2.8 Diabnext